UK Regulator Strengthens Rules On Conflicts Of Interest For Expert Advisors
The UK MHRA's code of practice has been updated in an effort to ensure that its decisions are based on “independent and impartial” expert advice and that the processes in place for managing conflicts of interest are “robust, consistent and clear to all.”
You may also be interested in...
The number of committees and groups advising the MHRA has now topped 50, and the agency believes that now is the time for a wide-ranging reform of the way it identifies and manages conflicts of interest among the members of those bodies.
Two new quality guidelines are needed to address the increase in applications for clinical trials and marketing authorizations of oligonucleotide- and peptide-based medicines, says the EU regulator.
The European Commission has laid out a number of possibilities for changing the EU framework on compulsory licensing to improve the availability of products in health emergencies. The options include extending the scope of compulsory licences beyond patents to other forms of protection such as data exclusivity.